Product Images Duloxetine
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 11 images provide visual information about the product associated with Duloxetine NDC 50090-6281 by A-s Medication Solutions, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Structure - c5b0f981 45c3 4e15 b712 984b4a4f6a57 01
Figure 1 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 02
The given text describes a graph showing the proportion of patients experiencing relapse over time after the start of treatment with either a placebo or duloxetine. The graph uses a Kaplan-Meier estimator method to plot the data. The x-axis shows the time from randomization to relapse in days, while the y-axis shows the proportion of patients experiencing relapse. The graph indicates that treatment with duloxetine resulted in a lower proportion of patients experiencing relapse compared to treatment with a placebo over the given time frame.*
Figure 2 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 03
This is a graph showing the proportion of patients with relapse over time from randomization to relapse (measured in days) for a placebo and a drug called Duloxetine. The graph uses the Kaplan-Meier estimator method. There are no other details available in the given text.*
Figure 1 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 04
Figure 2 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 05
fig 5 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 06
The text provides a chart showing the percentage of patients improved based on the level of pain improvement from the baseline. The chart includes data for patients taking Duloxetine 60mg twice daily, Duloxetine 60mg once daily, and a placebo. The chart displays ten different levels of pain improvement, ranging from greater than 0% improvement to 100% improvement.*
fig 6 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 07
This table shows the percentage of patients who experienced improvement in pain from baseline after receiving Duloxetine at different doses and a placebo. The table also shows the percentage improvement in pain for each group.*
Figure 8 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 08
This is a graph showing the percentage of patients who experienced an improvement in pain from baseline after being treated with placebo or Duloxetine 60/120 mg once daily. The x-axis represents the percentage of improvement in pain, while the y-axis represents the number of patients. However, there isn't enough information to determine the exact percentage of patients improved for Duloxetine compared to the Placebo group.*
Figure 9 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 09
The text provides a chart showing the percentage of patients improved with Duloxetine 60 mg versus a Placebo, without any specific context of a medical treatment or ailment. It also presents a graph showing the percentage improvement in pain from a baseline. Therefore, it seems to be a statistical analysis of the effectiveness of a drug in reducing pain.*
Figure 10 - c5b0f981 45c3 4e15 b712 984b4a4f6a57 10
Label Image - lbl500906281
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.